☆ 4.8 Review

The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Turning chiral peptides into a racemic supraparticle to induce the self-degradation of MDM2

Wenguang Yang et al.

Summary: A mild and simple self-assembly strategy was developed for the construction of peptide-derived chiral supramolecular nanomedicine with suitable pharmaceutical properties. The study demonstrated the potential of chiral supramolecular nanomedicine in suppressing tumor progression and enhancing tumor immunotherapy.

JOURNAL OF ADVANCED RESEARCH (2023)

Add to Collection

Review Cell Biology

Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics

Shuchan Li et al.

Summary: Idiopathic pulmonary fibrosis is a progressive lung disease characterized by pulmonary function loss, while drug-induced interstitial lung disease is a severe adverse effect of certain drugs. Animal models play a key role in understanding the molecular mechanisms of PF pathogenesis and developing therapeutic strategies.

CELL BIOLOGY AND TOXICOLOGY (2022)

Add to Collection

Article Cell Biology

Human mesenchymal stem cells

Xiaoyong Chen et al.

Summary: Mesenchymal stem cells (MSCs) have potential for cell therapy and tissue regeneration due to their properties, but their heterogeneity poses challenges. The "Human Mesenchymal Stem Cells" guidelines provide standards for quality control and technical specifications, aiming to accelerate the international standardization of MSCs for clinical development and therapeutic applications.

CELL PROLIFERATION (2022)

Add to Collection

Article Medicine, Research & Experimental

Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapy

Wangxiao He et al.

Summary: By camouflaging with the membrane from milk-derived extracellular vesicles (ME), researchers have successfully developed an oral nanomedicine constructed from chiral peptides, which remains stable during gastrointestinal absorption and blood circulation, and shows effectiveness in tumor therapy. The de novo design of this bionic chiral-peptide supramolecule provides a practicable strategy for the construction of biomimetic chiral peptide-derived nanostructures that can be taken orally, and likely boosts chiral nanomedicine discovery efforts for a wider range of diseases including cancer.

THERANOSTICS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

A Bionic-Homodimerization Strategy for Optimizing Modulators of Protein-Protein Interactions: From Statistical Mechanics Theory to Potential Clinical Translation

Jin Yan et al.

Summary: This study introduces a new method to calculate the affinity of PPI modulators and significantly increases the affinity of PPI modulators through a simple homodimerization strategy.

ADVANCED SCIENCE (2022)

Add to Collection

Article Genetics & Heredity

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma

Aimin Jiang et al.

Summary: This study constructed and validated a prognostic model for LUAD by integrating 10x scRNA-seq and bulk RNA-seq data. Two distinct subtypes with different prognosis and immune characteristics were observed in the population.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Medicine, Research & Experimental

PD-1/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis

Youliang Zhao et al.

Summary: This study demonstrates the potential value of immune checkpoint inhibitors, particularly PD-1/PD-L1 inhibitors, in the treatment of silica-induced pulmonary fibrosis. The findings suggest that these inhibitors can modulate immune system disruption caused by silica exposure and provide new ideas for the treatment of fibrosis-related diseases.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Article Respiratory System

Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosis

Katharina Heinzelmann et al.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Multidisciplinary Sciences

Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis

Abhalaxmi Singh et al.

Summary: This study explores the potential of mannose-targeted nanoparticles for treating lung fibrosis by delivering TGF beta-siRNA into profibrotic macrophages, inhibiting the development of fibrosis.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Multidisciplinary Sciences

PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways

Xia Guo et al.

Summary: PD-L1 may promote pulmonary fibrosis through both Smad3 and beta-catenin signaling, and may represent a novel interventional target for IPF.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Cell & Tissue Engineering

Single-Cell RNA Sequencing Reveals the Interaction of Injected ADSCs with Lung-Originated Cells in Mouse Pulmonary Fibrosis

Mamatali Rahman et al.

Summary: This study demonstrates the interaction between adipose-derived mesenchymal stem cells (ADSCs) and lung-originated cells in a pulmonary fibrosis (PF) model using single-cell RNA sequencing. The treatment with ADSCs altered the transcriptomic profile and composition of lung cells, particularly macrophages. The injected ADSCs increased the number of anti-inflammatory lung macrophages and reduced further inflammation and fibrosis in the lung.

STEM CELLS INTERNATIONAL (2022)

Add to Collection

Review Pharmacology & Pharmacy

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis

Jincheng Wang et al.

Summary: This article discusses the progress made in understanding the complex interpretation of the cause of IPF, emphasizing the importance of the PI3K/AKT signaling pathway in IPF development, and explores the potential benefits of PI3K/AKT inhibitors in IPF treatment.

ACTA PHARMACEUTICA SINICA B (2022)

Add to Collection

Review Multidisciplinary Sciences

Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology

Tuan Hiep Tran et al.

Summary: Nanomedicine has potential in oncology field, but only a few products have been approved. Immunotherapy, as a new direction in cancer treatment, still requires further development. Using PD-1/PD-L1-targeting nanocarriers can enhance treatment outcomes.

ROYAL SOCIETY OPEN SCIENCE (2022)

Add to Collection

Article Cell Biology

Cell-Surface Programmed Death Ligand-1 Expression Identifies a Sub-Population of Distal Epithelial Cells Enriched in Idiopathic Pulmonary Fibrosis

Negah Ahmadvand et al.

Summary: This study identified a population of cells in the lungs of patients with idiopathic lung fibrosis that express CD274 and exhibit characteristics of alveolar epithelial progenitor cells. The expansion of these cells in an ex vivo assay suggests their potential role as progenitor cells. However, inhibiting CD274 may further damage the already compromised lung epithelial compartment.

CELLS (2022)

Add to Collection

Article Environmental Sciences

Lung microbiome and transcriptome reveal mechanisms underlying PM2.5 induced pulmonary fibrosis

Qiyue Jia et al.

Summary: Airborne fine particulate matter (PM2.5) is considered a risk factor for lung fibrosis. This study investigated the potential mechanisms of PM2.5-induced pulmonary fibrosis and the impact of PM2.5-induced alterations in miRNAs and the lung microbiota in mice models. The results showed that PM2.5 affected the microbial community composition and differentially expressed miRNAs enriched in pathways related to microbial functions. A target miRNA, miR-149-5p, may be a key factor triggering pulmonary fibrosis. The study provides new insights into the progression of pulmonary fibrosis.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

Add to Collection

Article Engineering, Biomedical

Developmentally engineered bio-assemblies releasing neurotrophic exosomes guide in situ neuroplasticity following spinal cord injury

Jin Yan et al.

Summary: The emerging tissue-engineered bio-assemblies are revolutionizing regenerative medicine by providing a potential program to support the clinical translation of stem-cell-derived treatments. By using a developmentally engineered strategy, mesenchymal stem cells (MSC) can be assembled into a bio-assembly called Spinor, which promotes the treatment of spinal cord injury by promoting axonal regeneration and supporting the neuroplasticity of the spinal cord in vivo.

MATERIALS TODAY BIO (2022)

Add to Collection

Article Immunology

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Rodney Cheng-En Hsieh et al.

Summary: Radiation therapy induces up-regulation of CD47 and PD-L1 through the ATR-mediated DNA repair signaling pathway in CRC cells, which limits TAA cross-presentation and immune activation. Combination therapy with anti-SIRP alpha and anti-PD-1 reverses immune resistance, promotes TAA cross-presentation and robust antitumor immune priming.

SCIENCE IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor

Wenxian Wang et al.

Summary: ICIs have shown significant efficacy in treating various types of cancer, but the increasing incidence of CIP poses challenges for clinicians. To address this, Chinese experts conducted in-depth discussions and established a consensus on the multidisciplinary management of CIP to guide its diagnosis and treatment.

THORACIC CANCER (2022)

Add to Collection

Article Oncology

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

Yan Wang et al.

Summary: The newly designed CD47/PD-L1 bispecific antibody, IBI322, effectively inhibits CD47-SIRP alpha signal, promotes tumor cell phagocytosis, accumulates in PD-L1-positive tumors, shows synergistic therapeutic effects, and has minimal impact on red blood cells, making it a promising option for cancer treatment.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection

Review Medicine, Research & Experimental

Immune dysregulation as a driver of idiopathic pulmonary fibrosis

Kevin Shenderov et al.

Summary: IPF is a debilitating disease with limited treatment options, with lung transplantation being the only cure. Recent research has highlighted immune dysregulation as a key factor in the pathophysiology of the disease, suggesting that a better understanding of the immune system's role in IPF may lead to the development of targeted therapies.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Review Oncology

Regulation of PD-L1 expression in the tumor microenvironment

Ming Yi et al.

Summary: PD-L1 expression is regulated by various factors, impacting the treatment effect and patient selection. Understanding the mechanisms of PD-L1 regulation helps enhance the efficacy of immunotherapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

Adam D. Cotton et al.

Summary: AbTACs are fully recombinant bispecific antibodies that recruit membrane-bound E3 ligases for the degradation of cell-surface proteins. This new archetype represents a method within the PROTAC field to target cell-surface proteins with fully recombinant biological molecules.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Add to Collection

Article Plant Sciences

Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis

Dong Wang et al.

Summary: Our study demonstrates that Gancao Ganjiang decoction positively affects IPF by regulating the PD-1/TGF-beta 1/IL-17A pathway, suggesting its potential as a therapeutic agent for idiopathic pulmonary fibrosis.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?

Sara Lettieri et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with unknown cause, associated with an increased risk of lung cancer. Recent research suggests that immune checkpoint inhibition could be a rational treatment approach for IPF. Understanding the immune microenvironment of lung cancer has diagnostic and therapeutic implications for IPF.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Immunology

Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice

Jing Qu et al.

Summary: Aging is a significant risk factor for progressive human idiopathic pulmonary fibrosis (IPF), with MDM4 identified as a key regulator in fibrotic lung lesions. Inhibition of MDM4 and activation of the p53 pathway by reducing matrix stiffness promotes resolution of lung fibrosis in aged mice, suggesting a potential therapeutic target for persistent lung fibrosis associated with aging.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Review Oncology

Challenges and advances in clinical applications of mesenchymal stromal cells

Tian Zhou et al.

Summary: MSC therapy for clinical applications faces challenges due to inconsistent criteria for MSCs identity and their inherited heterogeneity. Strategies have been developed to overcome these challenges with the emergence of advanced biological techniques and substantial improvements in bio-engineered materials.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Article Toxicology

Macrophage autophagy protects mice from cerium oxide nanoparticle-induced lung fibrosis

Balasubramanyam Annangi et al.

Summary: Exposure to CeO2 NP in mice induces progressive and dose-dependent lung fibrosis in bronchiolar and alveolar walls, accompanied by autophagy activation. Inhibition of macrophagic autophagy provides protection against alveolar fibrosis, by modulating macrophage polarization towards M2 phenotype.

PARTICLE AND FIBRE TOXICOLOGY (2021)

Add to Collection

Article Respiratory System

Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma

Aimin Jiang et al.

Summary: This study identified a 16-autophagy-related lncRNA prognostic model with significant prognostic value for LUAD patients, suggesting potential predictive factors and therapeutic targets in these individuals.

JOURNAL OF THORACIC DISEASE (2021)

Add to Collection

Review Cell Biology

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis

Shengnan Yang et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with unknown causes, and currently the only medications that can slow down the progression of the disease and improve survival rate are pirfenidone and nintedanib. The use of mesenchymal stem cells (MSCs) provides a new hope for treating interstitial lung disease, but optimal treatment protocols are still lacking.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Role and mechanisms of autophagy in lung metabolism and repair

Xue Li et al.

Summary: Autophagy plays a crucial role in maintaining lung cell survival and repairing damaged tissue. Lung tissue contains specific stem/progenitor cell populations responsible for epithelial repair. Additionally, injury-induced lung fibrosis alters glucose and fatty acid metabolism in lung stem/progenitor cells.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Add to Collection

Article Oncology

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity

Shih-Hsun Chen et al.

Summary: The study developed a novel affinity-tuned bispecific antibody targeting CD47 and PD-L1 to antagonize innate and adaptive immune checkpoint pathways. This antibody showed enhanced selectivity in the tumor microenvironment and improved therapeutic window compared to monotherapies or combination therapies with alpha CD47 and alpha PD-L1. The bispecific treatment uniquely modulated myeloid and T cells, providing potential for clinical development to improve patient outcomes over current PD-(L)1 and CD47-targeted therapies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Medicine, General & Internal

PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis

Sissel Kronborg-White et al.

Summary: The study found a higher incidence of membrane-bound PD-L1 (mPD-L1) expression in alveolar and/or bronchiolar epithelial cells in patients with idiopathic pulmonary fibrosis (IPF) compared to other interstitial lung diseases (ILDs). This suggests a potential role of mPD-L1 in the pathogenesis of IPF, indicating the need for further larger studies to explore its implications in this patient population.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Chemistry, Multidisciplinary

De Novo Nano-Erythrocyte Structurally Braced by Biomimetic Au(I)-peptide Skeleton for MDM2/MDMX Predation toward Augmented Pulmonary Adenocarcinoma Immunotherapy

Xiaoqiang Zheng et al.

Summary: The research developed a new class of cell-mimicking nanomedicine using oligomeric Au(I)-peptide complex to create erythrocyte-mimicking nano-cells, which effectively restored p53 and p73 and augmented antitumor immunity. This study suggests that MDM2/MDMX degradation is a potential therapeutic paradigm to synergize anti-PD1 immunotherapy for LUAD, and cell-mimicking nanoparticles with bionic skeletons hold promise in revolutionizing nanomedicine for various human diseases.

SMALL (2021)

Add to Collection

Article Multidisciplinary Sciences

Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients

Ho Cheol Kim et al.

Summary: Patients with idiopathic pulmonary fibrosis (IPF) who develop lung cancer show different clinical characteristics, lung function, and prognosis compared to lung cancer patients without IPF. Treatment outcomes for patients with lung cancer and IPF are generally poor, with a higher rate of acute exacerbation.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Immunology

Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Eleanor Valenzi et al.

Summary: IPF and SSc-ILD exhibit differences in cell types and pathways, providing new insights into the diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Selective Degradation of PD-L1 in Cancer Cells by Enzyme-Instructed Self-Assembly

Yuhan Wang et al.

Summary: A novel strategy utilizing self-assembly between ALP and PD-L1 to selectively degrade PD-L1 in tumor cells is reported. This strategy selectively encapsulates PD-L1 in nanomaterials for further degradation, showing potential for inhibiting tumor growth in animal models.

ADVANCED FUNCTIONAL MATERIALS (2021)

Add to Collection

Article Respiratory System

Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis

Yoshio Nakahara et al.

Summary: The prognosis of elderly individuals with idiopathic pulmonary fibrosis (IPF) remains poor, with fibroblastic foci representing focal areas of active fibrogenesis in IPF. Fibroblast heterogeneity hampers the understanding of pulmonary fibrosis pathogenesis. This study highlights the anti-fibrotic properties of fibroblasts positive for meflin, providing insight into potential therapeutic targets for pulmonary fibrosis.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Article Immunology

The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis

Shan-Shan Liu et al.

Summary: Recruitment of immune cells to the site of inflammation by CCL1 is crucial in inflammatory diseases, including pulmonary fibrosis. The study found that alveolar macrophages and CD4(+) T cells are major producers of CCL1, and targeting CCL1 expression can attenuate the pathology of PF.

IMMUNITY (2021)

Add to Collection

Article Cell Biology

Autophagy, Apoptosis, the Unfolded Protein Response, and Lung Function in Idiopathic Pulmonary Fibrosis

Pawan Sharma et al.

Summary: The study found that cell stress markers in lung tissue of IPF patients are associated with lung function deficits, with co-localization of UPR and autophagy markers positively correlated with increased lung function.

CELLS (2021)

Add to Collection

Article Medicine, Research & Experimental

Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment

I-Ying Kuo et al.

Summary: Rab37 regulates IL-6 secretion in macrophages to induce M2 polarization, promoting PD-1 expression in CD8(+) T cells. Tumors with high stromal Rab37 and IL-6 levels are associated with immunotherapeutic resistance and poor prognosis in lung cancer patients.

THERANOSTICS (2021)

Add to Collection

Article Medicine, Research & Experimental

A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity

Siqi Yan et al.

Summary: This study designed a peptide-based molecular glue to target the tumor-driving protein MDMX for degradation, restoring the anti-cancer function of p53 and p73. The nanoengineered complex exhibited potent anti-cancer activities in animal models and maintained a favorable safety profile, bridging the gap between peptides and PROTACs for potential development in disease treatment.

THERANOSTICS (2021)

Add to Collection

Article Cell Biology

Regulation of sister chromatid cohesion by nuclear PD-L1

Jia Yu et al.

CELL RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis

Taylor S. Adams et al.

SCIENCE ADVANCES (2020)

Add to Collection

Article Multidisciplinary Sciences

Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis

Arun C. Habermann et al.

SCIENCE ADVANCES (2020)

Add to Collection

Review Cell Biology

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors

Qingyang Lei et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction

Jin Yan et al.

NANO LETTERS (2020)

Add to Collection

Article Cell Biology

PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer

Wendan Yu et al.

CELL DEATH & DISEASE (2020)

Add to Collection

Article Cell Biology

Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy

Yang Gao et al.

NATURE CELL BIOLOGY (2020)

Add to Collection

Article Cell Biology

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

Caterina Costa et al.

CELL DEATH & DISEASE (2020)

Add to Collection

Article Engineering, Environmental

De novo supraparticle construction by a self-assembled Janus cyclopeptide to tame hydrophilic microRNA and hydrophobic molecule for anti-tumor cocktail therapy and augmented immunity

Junjun She et al.

CHEMICAL ENGINEERING JOURNAL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice

Ae Rin Baek et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Add to Collection

Article Medicine, Research & Experimental

A general-purpose Nanohybrid fabricated by Polymeric Au(I)-peptide precursor to wake the function of Peptide Therapeutics

Jin Yan et al.

THERANOSTICS (2020)

Add to Collection

Article Immunology

Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles

Daping Yang et al.

IMMUNITY (2019)

Add to Collection

Article Oncology

Autophagy inhibition enhances PD-L1 expression in gastric cancer

Xiaojuan Wang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Biology

Single-cell RNA sequencing profiling of the effects of aging on alveolar stem cells

Tingting Lv et al.

SCIENCE CHINA-LIFE SCIENCES (2019)

Add to Collection

Review Oncology

The clinical significance of soluble PD-1 and PD-L1 in lung cancer

Taher Abu Hejleh et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)

Add to Collection

Review Medicine, General & Internal

Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?

JanWillem Duitman et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Add to Collection

Review Medicine, Research & Experimental

Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis

Yu Jing-Ze et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Add to Collection

Article Critical Care Medicine

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis

Paul A. Reyfman et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Add to Collection

Article Immunology

Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage

Dvir Aran et al.

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Oncology

Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway

K. Kondo et al.

LEUKEMIA (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Self-Assembled Peptide-Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery

Jin Yan et al.

ACS NANO (2018)

Add to Collection

Article Physiology

The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFN-γ-producing γδT cells in mice

Remo C. Russo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice

Ke Ni et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Deletion of c-FLIP from CD11b(hi) Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis

Alexandra L. McCubbrey et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)

Add to Collection

Article Cell Biology

Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux

Kui Wang et al.

AUTOPHAGY (2018)

Add to Collection

Article Engineering, Biomedical

Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy

Fan Niu et al.

BIOMATERIALS (2018)

Add to Collection

Review Immunology

When worlds collide: Th17 and Treg cells in cancer and autoimmunity

Hannah M. Knochelmann et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2018)

Add to Collection

Article Oncology

Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer

Yusuke Okuma et al.

CLINICAL LUNG CANCER (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis

Jessica Lawrence et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Metformin reverses established lung fibrosis in a bleomycin model

Sunad Rangarajan et al.

NATURE MEDICINE (2018)

Add to Collection

Article Anatomy & Morphology

Impact of Treg on other T cell subsets in progression of fibrosis in experimental lung fibrosis

Kaustav Chakraborty et al.

TISSUE & CELL (2018)

Add to Collection

Article Immunology

Expression of Programmed Death-Ligand 1 by Human Colonic CD90(+) Stromal Cells Differs Betweem Ulcerative Colitis and Crohn's Disease and Determines Their Capacity to Suppress Th1 Cells

Ellen J. Beswick et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Chemistry, Physical

Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch

Wangxiao He et al.

CHEMISTRY OF MATERIALS (2018)

Add to Collection

Article Respiratory System

Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study

Dragana Jovanovic et al.

JOURNAL OF THORACIC DISEASE (2018)

Add to Collection

Review Oncology

Soluble immune checkpoints in cancer: production, function and biological significance

Daqian Gu et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Add to Collection

Article Medicine, Research & Experimental

Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery

Zhenyuan Bian et al.

THERANOSTICS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis

Ellyse Cipolla et al.

FASEB JOURNAL (2017)

Add to Collection

Article Immunology

Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span

Alexander V. Misharin et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Add to Collection

Article Multidisciplinary Sciences

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity

Sydney R. Gordon et al.

NATURE (2017)

Add to Collection

Article Multidisciplinary Sciences

The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease

Alexandra Paun et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Respiratory System

Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis

Ziliang Hou et al.

RESPIRATORY RESEARCH (2017)

Add to Collection

Article Pathology

p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis

Shwetha K. Shetty et al.

AMERICAN JOURNAL OF PATHOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation

Lindsay J. Celada et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)

Add to Collection

Article Oncology

PDL1 Regulation by p53 via miR-34

Maria Angelica Cortez et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Article Oncology

PDL1 Regulation by p53 via miR-34

Maria Angelica Cortez et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Editorial Material Pathology

Regulatory T Cells in Idiopathic Pulmonary Fibrosis Too Much of a Good Thing?

Meagan W. Moore et al.

AMERICAN JOURNAL OF PATHOLOGY (2016)

Add to Collection

Article Respiratory System

Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis

Isis E. Fernandez et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Add to Collection

Article Oncology

Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib

Steffen Filskov Sorensen et al.

LUNG CANCER (2016)

Add to Collection

Editorial Material Biotechnology & Applied Microbiology

INFLAMMATORY DISEASE T cell-targeted antibody reverses fibrosis

Sarah Crunkhorn

NATURE REVIEWS DRUG DISCOVERY (2016)

Add to Collection

Article Medicine, Research & Experimental

Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis

Yan Xu et al.

JCI INSIGHT (2016)

Add to Collection

Article Cell Biology

Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGF1

Meredith L. Sosulski et al.

AGING CELL (2015)

Add to Collection

Article Critical Care Medicine

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Add to Collection

Article Cell Biology

Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis

Sandra Cabrera et al.

AUTOPHAGY (2015)

Add to Collection

Article Critical Care Medicine

The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis

Sara Tomassetti et al.

CHEST (2015)

Add to Collection

Article Immunology

Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance

Shanshan Xiong et al.

IMMUNOBIOLOGY (2015)

Add to Collection

Review Immunology

IL-6 as a keystone cytokine in health and disease

Christopher A. Hunter et al.

NATURE IMMUNOLOGY (2015)

Add to Collection

Article Immunology

Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN- γ - secreting T-cell Ratios in Bleomycin-treated Mice

Keunhee Oh et al.

IMMUNE NETWORK (2015)

Add to Collection

Article Multidisciplinary Sciences

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential

Jie Liu et al.

PLOS ONE (2015)

Add to Collection

Article Critical Care Medicine

Future Directions in Idiopathic Pulmonary Fibrosis Research

Timothy S. Blackwell et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Add to Collection

Article Critical Care Medicine

Blockade of the Programmed Death-1 Pathway Restores Sarcoidosis CD4+ T-Cell Proliferative Capacity

Nicole A. Braun et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Add to Collection

Article Biochemistry & Molecular Biology

A Complex between Atg7 and Caspase-9 A NOVEL MECHANISM OF CROSS-REGULATION BETWEEN AUTOPHAGY AND APOPTOSIS

Jie Han et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Add to Collection

Article Immunology

Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis

Thanh-Thuy T. Le et al.

JOURNAL OF IMMUNOLOGY (2014)

Add to Collection

Article Immunology

TLR4 Activation Enhances the PD-L1-Mediated Tolerogenic Capacity of Colonic CD90+ Stromal Cells

Ellen J. Beswick et al.

JOURNAL OF IMMUNOLOGY (2014)

Add to Collection

Article Medicine, General & Internal

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Pharmacology & Pharmacy

Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice

Ying Chen et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

Limo Chen et al.

NATURE COMMUNICATIONS (2014)

Add to Collection

Article Physiology

Insufficient autophagy in idiopathic pulmonary fibrosis

Jun Araya et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)

Add to Collection

Article Immunology

Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment

R. W. J. Meijers et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)

Add to Collection

Article Cell Biology

Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis

Jose D. Herazo-Maya et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Add to Collection

Article Physiology

Hypermethylation-mediated silencing of p14ARF in fibroblasts from idiopathic pulmonary fibrosis

Jose Cisneros et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)

Add to Collection

Article Physiology

Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system

Yashodhar P. Bhandary et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Regulation of Airway and Alveolar Epithelial Cell Apoptosis by p53-Induced Plasminogen Activator Inhibitor-1 during Cigarette Smoke Exposure Injury

Shwetha K. Shetty et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)

Add to Collection

Article Respiratory System

The role of all-trans retinoic acid in bleomycin-induced pulmonary fibrosis in mice

Zhaoxing Dong et al.

EXPERIMENTAL LUNG RESEARCH (2012)

Add to Collection

Article Immunology

Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: Possible role of Th17 cells in chronic lung pathology

Neerad C. Mishra et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2012)

Add to Collection

Article Immunology

RGS16 Attenuates Pulmonary Th2/Th17 Inflammatory Responses

Sucharita P. Shankar et al.

JOURNAL OF IMMUNOLOGY (2012)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

Thomas A. Wynn et al.

NATURE MEDICINE (2012)

Add to Collection

Article Multidisciplinary Sciences

Tregs Promote the Differentiation of Th17 Cells in Silica-Induced Lung Fibrosis in Mice

Laiyu Song et al.

PLOS ONE (2012)

Add to Collection

Article Multidisciplinary Sciences

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Add to Collection

Article Cell & Tissue Engineering

Immunosuppressive Properties of Mesenchymal Stem Cells

Mohamed Abumaree et al.

STEM CELL REVIEWS AND REPORTS (2012)

Add to Collection

Review Immunology

How mesenchymal stem cells interact with tissue immune responses

Yufang Shi et al.

TRENDS IN IMMUNOLOGY (2012)

Add to Collection

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Add to Collection

Review Oncology

Mesenchymal stromal cell 'licensing': a multistep process

M. Krampera

LEUKEMIA (2011)

Add to Collection

Review Multidisciplinary Sciences

Autophagy in immunity and inflammation

Beth Levine et al.

NATURE (2011)

Add to Collection

Article Immunology

Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent

Mark S. Wilson et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V

Ruedi K. Braun et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)

Add to Collection

Article Immunology

Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma Model

Ayumi Yoshizaki et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection

Article Multidisciplinary Sciences

CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis

Syed R. Gilani et al.

PLOS ONE (2010)

Add to Collection

Article Biochemistry & Molecular Biology

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Siddhartha Jaiswal et al.

CELL (2009)

Add to Collection

Article Biochemistry & Molecular Biology

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Ravindra Majeti et al.

CELL (2009)

Add to Collection

Article Immunology

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

Meghan A. Koch et al.

NATURE IMMUNOLOGY (2009)

Add to Collection

Article Immunology

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

Xuexian O. Yang et al.

IMMUNITY (2008)

Add to Collection

Review Cell Biology

Autophagy: from phenomenology to molecular understanding in less than a decade

Daniel J. Klionsky

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Add to Collection

Article Respiratory System

CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis -: art. no. 81

Z Daniil et al.

RESPIRATORY RESEARCH (2005)

Add to Collection

Review Immunology

CD28 extinction in human T cells: altered functions and the program of T-cell senescence

AN Vallejo

IMMUNOLOGICAL REVIEWS (2005)

Add to Collection

Article Biochemistry & Molecular Biology

ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis

M Krasilnikov et al.

ONCOGENE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.